Veradigm (NASDAQ:MDRX) Now Covered by Analysts at StockNews.com

StockNews.com assumed coverage on shares of Veradigm (NASDAQ:MDRX) in a research report sent to investors on Thursday morning. The firm issued a hold rating on the software maker’s stock.

Veradigm Stock Performance

NASDAQ:MDRX opened at $9.25 on Thursday. The stock’s fifty day moving average price is $9.54 and its two-hundred day moving average price is $9.11. Veradigm has a 1 year low of $5.01 and a 1 year high of $13.62.

Institutional Investors Weigh In On Veradigm

Several institutional investors have recently made changes to their positions in MDRX. Vanguard Group Inc. increased its holdings in shares of Veradigm by 0.7% in the fourth quarter. Vanguard Group Inc. now owns 14,275,875 shares of the software maker’s stock worth $149,754,000 after purchasing an additional 95,291 shares during the period. Goldman Sachs Group Inc. increased its holdings in shares of Veradigm by 6.6% in the fourth quarter. Goldman Sachs Group Inc. now owns 1,596,684 shares of the software maker’s stock worth $16,749,000 after purchasing an additional 99,528 shares during the period. Tyro Capital Management LLC bought a new position in shares of Veradigm in the first quarter worth $9,055,000. Meadow Creek Wealth Advisors LLC bought a new position in shares of Veradigm in the first quarter worth $83,000. Finally, Innealta Capital LLC bought a new position in shares of Veradigm in the second quarter worth $38,000.

About Veradigm

Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.